ALGBE Global Bioenergies SA

Global Bioenergies sells to Repsol testing volumes of bio-isobutene derivatives for gasoline formulation

Global Bioenergies sells to Repsol testing volumes of bio-isobutene derivatives for gasoline formulation

        

Global Bioenergies sells to Repsol testing volumes of

bio-isobutene derivatives for gasoline formulation

Evry, 19 September 2022 - Repsol, the Spain-based multi-energy company, signed a purchase order for a volume of Global Bioenergies’ full-bio-ETBE to be used for formulation and performance assessment of gasoline.

ETBE is widely used as a high-octane component in gasoline.

However, standard ETBE, which is added up to around 15% in current gasoline, is only partially renewable as it is currently produced from renewable ethanol combined with fossil isobutene.

To produce full-bio-ETBE, Global Bioenergies converted wood residues into isobutene and combined it with renewable ethanol.

Using full-bio-ETBE in gasoline formulation would automatically increase the percentage of renewables in gasoline used for road and air transportation, and thus reduce the CO2 emissions of such energy streams. It could also be one of the key components to produce renewable gasoline and get closer to the long-term goal of net zero carbon emissions.

Bernard Chaud, Director of Industrial Strategy at Global Bioenergies, comments: “We are thrilled to see our collaboration with Repsol move to the next level. The construction of our production unit in Pomacle is now completed, and we will soon be in a position to supply larger quantities of bio-isobutene and derivatives, which can serve to design, prepare and test high performance formulations of renewable fuels.”

About GLOBAL BIOENERGIES

Global Bioenergies converts plant-derived resources into compounds used in the cosmetics industry, as well as the energy and materials sectors. After launching the first long-lasting and natural make-up brand LAST® in 2021, Global Bioenergies is now marketing Isonaturane® 12, its key ingredient, to major cosmetics companies to improve the naturalness of their formulas whilst improving their carbon footprint. In the long run, Global Bioenergies is also aiming at cutting CO2 emissions in the aviation and road sector and thereby curb global warming. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 - ALGBE).

Receive information about Global Bioenergies directly by subscribing to our news feed on -bioenergies.com

Follow us on LinkedIn:

Contacts

GLOBAL BIOENERGIES



 



Ronan Euzen

Chief Business Development Officer





 



 
PRESS RELATIONS



 



Iva Baytcheva





 



Nicolas Daniels





 

Attachment



EN
19/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Global Bioenergies SA

 PRESS RELEASE

GLOBAL BIOENERGIES: judicial liquidation and delisting of shares

GLOBAL BIOENERGIES: judicial liquidation and delisting of shares Evry, 01 December 2025 – 5:30pm: At the hearing to examine the bids held on November 24, the Evry Commercial Court examined the two final takeover bids submitted. In a ruling handed down today, neither bid was accepted by the Court, the first bid was rejected due to the lack of employee retention and the second on the grounds that it did not meet the conditions for a satisfactory takeover. The Evry Commercial Court therefore decided to convert the receivership procedure into judicial liquidation and appointed Maître Alain-Fra...

 PRESS RELEASE

GLOBAL BIOENERGIES : liquidation judiciaire et radiation des actions à...

GLOBAL BIOENERGIES : liquidation judiciaire et radiation des actions à venir Evry, le 1er décembre 2025 : Lors de l’audience d’examen des offres qui s’est tenue le 24 novembre dernier, le Tribunal de Commerce d’Evry a examiné les deux offres de reprise finales déposées. Aux termes d’un jugement rendu ce jour, aucune des deux offres n’a été retenue par le Tribunal, la première offre en raison de l’absence de reprise de salariés et la seconde au motif qu’elle ne remplissait pas les conditions permettant une reprise satisfaisante. Le Tribunal de Commerce d’Evry a ainsi décidé de convertir le ...

 PRESS RELEASE

Global Bioenergies: postponement of the takeover offers review hearing...

Global Bioenergies: postponement of the takeover offers review hearing to 24 November PRESS RELEASE Global Bioenergies: postponement of the takeover offers review hearing to 24 November Evry, 04 November 2025 – 05:45 p.m: The hearing which was held yesterday at the Commercial Court of Evry concluded with the decision to postpone until 24 November 2025 the review of the offers to take over Global Bioenergies’ activities. The new deadline for submitting the offers has been set up on 12 November 2025. As a reminder, the company had initiated a pre-pack sale process on 03 June 2025 and t...

 PRESS RELEASE

Global Bioenergies : renvoi de l’audience d’examen des offres au 24 no...

Global Bioenergies : renvoi de l’audience d’examen des offres au 24 novembre COMMUNIQUE DE PRESSE Global Bioenergies : renvoi de l’audience d’examen des offres au 24 novembre Evry, le 04 novembre 2025 - 17h45 : L’audience qui s’est tenue hier au Tribunal de Commerce d’Evry s’est conclue sur la décision de renvoyer l’examen des offres de reprise des activités de la société Global Bioenergies au lundi 24 novembre 2025. Une nouvelle date limite de dépôt des offres a été fixée au 12 novembre 2025 à midi. Pour rappel, la Société s’était inscrite dans un processus de pré-pack cession le 3...

 PRESS RELEASE

Global Bioenergies: opening of a receivership procedure

Global Bioenergies: opening of a receivership procedure PRESS RELEASE Global Bioenergies: opening of a receivership procedure Evry, 29 September 2025 – 05:45 p.m: The Evry Commercial Court today opened a receivership procedure towards Global Bioenergies and appointed SCP Abitbol & Rousselet, represented by Maître Joanna Rousselet (previously the company's conciliator), as administrator. This procedure is a continuation of the pre-pack sale process initiated on 03 June 20251. The objective of this procedure is to evaluate and implement solutions that would make it possible to continue the ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch